Phosphatase of regenerating liver‐3 regulates cancer cell metabolism in multiple myeloma
Open Access
- 10 February 2021
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 35 (3), e21344
- https://doi.org/10.1096/fj.202001920rr
Abstract
Cancer cells often depend on microenvironment signals from molecules such as cytokines for proliferation and metabolic adaptations. PRL-3, a cytokine-induced oncogenic phosphatase, is highly expressed in multiple myeloma cells and associated with poor outcome in this cancer. We studied whether PRL-3 influences metabolism. Cells transduced to express PRL-3 had higher aerobic glycolytic rate, oxidative phosphorylation, and ATP production than the control cells. PRL-3 promoted glucose uptake and lactate excretion, enhanced the levels of proteins regulating glycolysis and enzymes in the serine/glycine synthesis pathway, a side branch of glycolysis. Moreover, mRNAs for these proteins correlated with PRL-3 expression in primary patient myeloma cells. Glycine decarboxylase (GLDC) was the most significantly induced metabolism gene. Forced GLDC downregulation partly counteracted PRL-3-induced aerobic glycolysis, indicating GLDC involvement in a PRL-3-driven Warburg effect. AMPK, HIF-1α, and c-Myc, important metabolic regulators in cancer cells, were not mediators of PRL-3’s metabolic effects. A phosphatase-dead PRL-3 mutant, C104S, promoted many of the metabolic changes induced by wild-type PRL-3, arguing that important metabolic effects of PRL-3 are independent of its phosphatase activity. Through this study, PRL-3 emerges as one of the key mediators of metabolic adaptations in multiple myeloma.Keywords
Funding Information
- Norges Teknisk-Naturvitenskapelige Universitet
This publication has 63 references indexed in Scilit:
- Oncogenic roles of PRL‐3 in FLT3‐ITD induced acute myeloid leukaemiaEMBO Molecular Medicine, 2013
- Serine, glycine and one-carbon units: cancer metabolism in full circleNature Reviews Cancer, 2013
- Cancer Cell Metabolism: One Hallmark, Many FacesCancer Discovery, 2012
- The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemiaMolecular Cancer, 2012
- Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell ProliferationScience, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- PRL-3, a Metastasis Associated Tyrosine Phosphatase, Is Involved in FLT3-ITD Signaling and Implicated in Anti-AML TherapyPLOS ONE, 2011
- A Versatile Viral System for Expression and Depletion of Proteins in Mammalian CellsPLOS ONE, 2009
- Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cellsBlood, 2008
- Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancerBritish Journal of Cancer, 2006